Analyze Diet
Equine veterinary journal2002; 33(7); 644-650; doi: 10.2746/042516401776249435

Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.

Abstract: Influenza and tetanus-specific antibodies of the IgG sub-isotypes are posively transferred to foals via colostrum and inhibit their response to inactivated influenza vaccines and tetanus toxoid. High titres of influenza antibodies of IgGa and IgGb subisotypes and tetanus antibodies of the IgGa, IgGb and IgG(T) subisotypes were detected in postsucking serum samples collected from foals born to mares that had received booster doses of multicomponent vaccines during the last 2 months of gestation. Thereafter, titres declined in an exponential manner but were still detectable in all foals at age 26 weeks, regardless of whether they had been vaccinated prior to age 26 weeks. Mean +/- s.e. half-life of decline of influenza IgGa antibodies (27.0 +/- 2.3 days) was significantly shorter than that of influenza IgGb antibodies (39.1 +/- 2.7 days; P<0.005). Tetanus IgGa and IgGb antibodies declined with half-lives of 28.8 +/- 3.0 and 34.8 +/- 5.1 days, respectively. Titres of tetanus IgG(T) antibodies were substantially higher than those of influenza IgG(T) antibodies in postsucking samples and remained so through age 26 weeks, declining with a half-life of approximately 35 days. Postsucking titres of tetanus and influenza antibodies of the IgA isotype were low and declined rapidly to undetectable levels. Yearlings showed significant increases in titre of influenza IgGa, IgGb and IgG(T) subisotype antibodies but no increase in influenza IgA antibodies in response to 2 doses of multicomponent vaccines containing tetanus toxoid and inactivated influenza A-1 and A-2 antigens. Yearlings also showed strong tetanus IgGa, IgGb and IgG(T) subisotype responses to one dose of vaccine and a substantial further rise in titre in response to administration of a second dose 3 weeks later, but failed to show an increase in titre of tetanus IgA antibodies. The influenza and tetanus IgGa, IgGb and IgG(T) subisotype responses of 6-month-old foals to vaccination followed the same pattern as those shown by yearlings but titres were generally lower. In contrast, 3-month-old foals failed to show increases in titre of either influenza or tetanus IgG subisotypes in response to 2 doses of vaccine and generally needed 1-3 additional booster doses of vaccine to achieve titres similar to those achieved by yearlings after 2 doses. Based on the finding that maternal antibodies exert a significant inhibitory effect on the response of foals to tetanus toxoid and inactivated influenza antigens, it is recommended that primary immunisation of foals born to vaccinated mares should not commence before age 6 months.
Publication Date: 2002-01-05 PubMed ID: 11770984DOI: 10.2746/042516401776249435Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research studies how maternal antibodies against influenza and tetanus affect the immune response of young horses (foals) when they are vaccinated against these diseases. It suggests that the timing of initial vaccinations should be delayed until the foal is at least six months old to account for the presence of these maternal antibodies.

Maternal Antibody Transfer and Its Implications

  • The study observes that influenza and tetanus-specific antibodies of the IgG sub-isotypes are passed from the mother to foal through the consumption of colostrum, the first milk produced after birth. These antibodies can inhibit the foal’s own immune response to inactive influenza vaccines and tetanus toxin.
  • High levels of specific sub-types of these antibodies were found in the foals after consuming colostrum, specifically foals from mares that received booster doses of multi-component vaccines in the last two months of their pregnancy.
  • These antibodies declined exponentially over time but were still detectable when the foals reached 26 weeks (approximately six months) of age. This was true regardless of whether the foal was vaccinated before reaching this age.
  • The study found that different types of these maternal antibodies declined at different rates.

The Impact of Maternal Antibodies on the Foal’s Response to Vaccination

  • Yearlings (one-year-old horses) showed an increase in certain antibody levels after receiving two doses of a multi-component vaccine containing tetanus poison and inactivated influenza antigens. This did not include an increase in influenza IgA antibodies.
  • However, yearlings did show a significant immune response to the tetanus vaccine in the form of increased tetanus IgGa, IgGb, and IgG(T) antibodies. A second dose boosted these levels even more, but did not result in an increase in tetanus IgA antibodies.

Recommendations from the Study

  • The response of foals to vaccination followed a similar pattern to that observed in yearlings, but the antibody levels were generally lower.
  • Interestingly, three-month-old foals showed no increase in certain antibodies in response to the first two vaccine doses and usually required one to three additional booster doses to achieve similar levels to yearlings after two doses.
  • Considering the influence of maternal antibodies on the foal’s immune response, the study suggests deferring the primary Immunisation of foals born to vaccinated mares until they are at least six months old.

Concluding, the study provides critical insights into the interaction between maternal antibodies and the immune response of foals to vaccination. The suggested delay in initial immunization could be influential for veterinary practitioners in maximizing the effectiveness of the foal’s immune response to influenza and tetanus vaccinations.

Cite This Article

APA
Wilson WD, Mihalyi JE, Hussey S, Lunn DP. (2002). Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet J, 33(7), 644-650. https://doi.org/10.2746/042516401776249435

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 33
Issue: 7
Pages: 644-650

Researcher Affiliations

Wilson, W D
  • Department of Medicine and Epidemiology (VM:VME), School of Veterinary Medicine, University of California, Davis 95616, USA.
Mihalyi, J E
    Hussey, S
      Lunn, D P

        MeSH Terms

        • Adjuvants, Immunologic / administration & dosage
        • Animals
        • Animals, Newborn / immunology
        • Animals, Suckling / immunology
        • Antibodies, Bacterial / blood
        • Antibodies, Viral / blood
        • Colostrum / immunology
        • Female
        • Horse Diseases / immunology
        • Horse Diseases / microbiology
        • Horse Diseases / virology
        • Horses
        • Immunity, Maternally-Acquired
        • Immunoglobulin G / analysis
        • Immunoglobulin G / blood
        • Influenza Vaccines / administration & dosage
        • Influenza Vaccines / immunology
        • Orthomyxoviridae Infections / immunology
        • Orthomyxoviridae Infections / veterinary
        • Pregnancy
        • Tetanus / immunology
        • Tetanus / veterinary
        • Tetanus Toxoid / administration & dosage
        • Tetanus Toxoid / immunology
        • Time Factors
        • Vaccination / methods
        • Vaccination / veterinary
        • Vaccines, Inactivated / administration & dosage
        • Vaccines, Inactivated / immunology

        Citations

        This article has been cited 13 times.
        1. Gomez DE, Wong D, MacNicol J, Dembek K. The fecal bacterial microbiota of healthy and sick newborn foals.. J Vet Intern Med 2023 Jan;37(1):315-322.
          doi: 10.1111/jvim.16596pubmed: 36519210google scholar: lookup
        2. Anna M, Łukasz M, Adam O, Chełmońska-Soyta A. Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life.. Sci Rep 2022 Sep 22;12(1):15795.
          doi: 10.1038/s41598-022-17532-1pubmed: 36138050google scholar: lookup
        3. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
          doi: 10.3390/vaccines10030398pubmed: 35335029google scholar: lookup
        4. Migdał A, Migdał Ł, Oczkowicz M, Okólski A, Chełmońska-Soyta A. Influence of Age and Immunostimulation on the Level of Toll-Like Receptor Gene (TLR3, 4, and 7) Expression in Foals.. Animals (Basel) 2020 Oct 26;10(11).
          doi: 10.3390/ani10111966pubmed: 33114637google scholar: lookup
        5. Jürgenschellert L, Krücken J, Austin CJ, Lightbody KL, Bousquet E, von Samson-Himmelstjerna G. Investigations on the occurrence of tapeworm infections in German horse populations with comparison of different antibody detection methods based on saliva and serum samples.. Parasit Vectors 2020 Sep 10;13(1):462.
          doi: 10.1186/s13071-020-04318-5pubmed: 32912340google scholar: lookup
        6. Tallmadge RL, Miller SC, Parry SA, Felippe MJB. Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.. PLoS One 2017;12(5):e0177831.
          doi: 10.1371/journal.pone.0177831pubmed: 28520789google scholar: lookup
        7. Hedegaard CJ, Heegaard PM. Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems.. Vet Immunol Immunopathol 2016 Jun;174:50-63.
          doi: 10.1016/j.vetimm.2016.04.007pubmed: 27185263google scholar: lookup
        8. Beeler JA, Eichelberger MC. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.. Microb Pathog 2013 Feb;55:9-15.
          doi: 10.1016/j.micpath.2012.11.013pubmed: 23247146google scholar: lookup
        9. Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.. Influenza Other Respir Viruses 2010 Nov;4(6):363-72.
        10. Ryan C, Giguère S. Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses.. Clin Vaccine Immunol 2010 Dec;17(12):1896-902.
          doi: 10.1128/CVI.00328-10pubmed: 20943883google scholar: lookup
        11. Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA. Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.. Antimicrob Agents Chemother 2009 Oct;53(10):4327-32.
          doi: 10.1128/AAC.00404-09pubmed: 19620328google scholar: lookup
        12. Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.. Equine Vet J 2009 Jan;41(1):87-92.
          doi: 10.2746/042516408x371937pubmed: 19301588google scholar: lookup
        13. Chen J, Zhang F, Fang F, Chang H, Chen Z. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.. BMC Infect Dis 2007 Oct 16;7:118.
          doi: 10.1186/1471-2334-7-118pubmed: 17939857google scholar: lookup